Sumitomo Mitsui Trust Group Inc. Trims Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Sumitomo Mitsui Trust Group Inc. reduced its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 10.7% in the 3rd quarter, Holdings Channel reports. The fund owned 275,630 shares of the company’s stock after selling 33,053 shares during the period. Sumitomo Mitsui Trust Group Inc.’s holdings in Henry Schein were worth $20,093,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently bought and sold shares of HSIC. Cromwell Holdings LLC raised its stake in Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock valued at $26,000 after purchasing an additional 170 shares during the last quarter. Summit Securities Group LLC acquired a new position in Henry Schein in the 2nd quarter valued at $31,000. Beach Investment Counsel Inc. PA acquired a new position in Henry Schein in the 2nd quarter valued at $37,000. Blue Trust Inc. raised its stake in Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after purchasing an additional 475 shares during the last quarter. Finally, Farther Finance Advisors LLC increased its stake in shares of Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after acquiring an additional 346 shares during the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Price Performance

Shares of NASDAQ:HSIC opened at $68.76 on Monday. The company has a current ratio of 1.42, a quick ratio of 0.82 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a 1 year low of $63.67 and a 1 year high of $82.63. The business has a fifty day simple moving average of $70.30 and a 200 day simple moving average of $69.57. The firm has a market cap of $8.57 billion, a price-to-earnings ratio of 28.30, a P/E/G ratio of 1.97 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same period last year, the business posted $1.32 earnings per share. The firm’s revenue was up .4% compared to the same quarter last year. As a group, sell-side analysts predict that Henry Schein, Inc. will post 4.78 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of analysts have issued reports on the company. Robert W. Baird cut their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a research note on Wednesday, August 7th. Evercore ISI increased their price target on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Baird R W upgraded Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Finally, Barrington Research reiterated an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a report on Wednesday, November 6th. Six equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, Henry Schein has a consensus rating of “Moderate Buy” and a consensus price target of $78.89.

Insider Activity

In other news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The trade was a 22.65 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 1.14% of the stock is currently owned by corporate insiders.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.